emjreviews.com8m
1 in 20 Adult Outpatients Hospitalised After RSV Diagnosis
Approximately 1 in 20 individuals diagnosed with RSV in outpatient settings were hospitalised within 28 days. Read more.
Apogee Therapeutics Highlights Progress and Best-in-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day
Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month ...